Business Daily Media

Men's Weekly

.

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc.

to launch and commercialise Libtayo® (cemiplimab), a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells, in South Korea and Taiwan.

Regeneron is a leading biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases. Libtayo® (cemiplimab) is currently approved for first-line monotherapy treatment of advanced non-small cell lung cancer (NSCLC), the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) and recurrent or metastatic cervical cancer in Korea. It is approved for monotherapy treatment of advanced NSCLC in Taiwan.

"We are excited to accelerate the availability of Libtayo® to patients in South Korea and Taiwan. With our proven track record and deep understanding of the complex biopharma environment in Asia, we are uniquely positioned to deliver innovative therapies to patients in the region. This also represents a significant milestone in our mission to make healthcare more accessible and improve patient outcomes, especially in the burgeoning oncology segment," said CEO of Zuellig Pharma, John Graham.

Libtayo®, which was invented using Regeneron's proprietary VelocImmune® technology, is currently approved by regulatory authorities in more than two dozen countries for various indications.
Hashtag: #ZuelligPharma #Regeneron #Oncology #Libtayo #Biotechnology #Healthcare #Pharmaceuticals



The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multibillion-dollar business covering 16 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

ZP Therapeutics, a division of Zuellig Pharma, is the commercialisation partner of choice for the healthcare industry with offices in 13 markets across Asia and over 2,500 associates. A catalyst in improving patient journeys and healthcare outcomes through commercial excellence, robust in-market capabilities and strong ethical principles, ZP Therapeutics is a trusted partner for expanding patient access and providing innovations to the healthcare community.

For more information, visit:

News from Asia

Jiaxing Invites Korean Influencers for In-Depth Cultural Tour, Breaking New Ground in Inbound Tourism with "Culture+"

SHANGHAI, CHINA - Media OutReach Newswire - 30 September 2025 - The "Relaxing Jiaxing" Korean Influencer Cultural Exploration Event took place from September 23 to 25, 2025, jointly organized by t...

HKSTP x Tatler Fire Up the Hong Kong Founder’s Spirit with Steven Bartlett, host of 'The Diary of a CEO' Podcast

Hong Kong startups and business leaders join renowned entrepreneur on his first Asia tour to explore the mindset behind successful founders HONG KONG SAR - Media OutReach Newswire - 30 September 2...

MSIG Singapore honoured for Leadership in Personal Lines and Underwriting Excellence

SINGAPORE - Media OutReach Newswire - 1 October 2025 - MSIG Singapore emerged as a double winner at the inaugural Asia Consumer Insurance Awards 2025, securing both Personal Lines Insurer of the ...

SIBUR offsets carbon footprint of client event in Istanbul

MOSCOW, RUSSIA - Media OutReach Newswire - 1 October 2025 - SIBUR offset the carbon footprint of a roundtable discussion held on 26 September 2025 for the company's international partners in Istan...

SNP Group Appoints Jelita Kamal as Chief Operating Officer for Asia Pacific

SNP creates new COO role to scale growth and operations across Asia Pacific Seasoned leader Jelita Kamal appointed to drive strategy, execution, and revenue Move reflect...

Shaping the Future of Hybrid Office Spaces in Singapore with Raw Design Consultants

SINGAPORE - Media OutReach Newswire - 1 October 2025 - The rise of hybrid work is reshaping how offices in Singapore are imagined and used. Beyond desks and meeting rooms, today’s workplaces are n...

BUMA International Group 1H 2025 Results Demonstrate Strong Recovery in 2Q25

JAKARTA, INDONESIA - Media OutReach Newswire - 1 October 2025 - PT BUMA Internasional Grup Tbk (BUMA International Group, IDX: DOID, "the Group") today announced its audited consolidated results ...

Nations’s First-of-its-Kind Endometriosis Scientific Workshop Aims to Improve the Quality of Life for Malaysian Women

Thomson Fertility (also known as TMC Fertility) together with Thomson Hospital Kota Damansara and Monash University Australia collaborate to bring together endometriosis experts from United Kingdom...

Amazon Singapore Rolls Out Line-up of Incredible Deals for Amazon Prime Big Deal Days 2025

Amazon Prime Big Deal Days returns to Singapore from 7 - 13 October with its longest event yet, offering seven days of incredible deals.

Chen Zhi Climate Action Challenge and Ministry of Environment Partner to Advance Youth Climate Solutions in Cambodia

PHNOM PENH, CAMBODIA - Media OutReach Newswire - 1 October 2025 - Cambodia's climate resilience efforts gained fresh momentum with the signing of a memorandum of understanding between the Ministry...

Minns Labor Government shutting down the Business Connect program

The NSW Opposition is concerned that the Labor government will shut down a support program that has assisted New South Wales businesses. In a media ...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...

Why it’s time telcos rethink location and put customer experience first

Maurice Zicman, Vice President - CX Strategy at TP in Australia unpacks why the telco industry must rethink old assumptions and focus on digital-f...

Sell by LayBy